Cancer researchers publish study on avidity enhancement of CAR T cells
May 25, 2022 -- A team of cancer researchers led by Dr. Marcela Maus have published a preclinical study detailing the use of the Lumicks z-Movi Cell Avidity Analyzer to provide more nuanced development of cancer treatments. The study focused on using Lumicks’ technology to identify chimeric antigen receptor (CAR) T cells that are best suited to treat acute myeloid leukemia. Read More
Lunaphore and Indica Labs combine spatial biology and pathology imaging platforms
May 13, 2022 -- Lunaphore and Indica Labs have partnered on the development of a biological research tool involving software from both companies. This new solution will involve a combination of Lunaphore’s Comet spatial biology platform and Indica Labs’ Halo digital pathology image analysis software. Read More
Avantor and Cytovance enter into plasmid manufacturing agreement
May 11, 2022 -- Avantor and Cytovance Biologics have entered into an agreement to advance the manufacturing of plasmids. This agreement will combine Avantor’s expertise in providing cell and gene therapy materials with Cytovance’s plasmid DNA manufacturing capabilities. Read More
Study of T-cell behavior predicts therapeutic differences in cancer outcomes
May 10, 2022 -- Researchers at Weill Cornell Medicine have published a study in Cancer Cell revealing a novel insight on the role of T cells in cancer therapies. The study focused on comparing the differences in behaviors of T cells in immunotherapy for metastatic melanoma to treatment outcomes. Read More
Lunaphore launches Comet antibody instrument in U.K.
May 9, 2022 -- Lunaphore installed its Comet Primary Antibodies instrument at Propath U.K., the first contract research organization in Europe to offer the service. Read More
Dotmatics debuts new antibody discovery software
May 9, 2022 -- Dotmatics has launched a new end-to-end software and cloud-based data management package: Biology Solution for Antibody Discovery. Read More
RedShift BioAnalytics releases biomolecule characterization technology
May 4, 2022 -- RedShift BioAnalytics has launched its novel Apollo technology for advanced microfluidic modulation spectroscopy. This technology enables highly sensitive and precise measurement of biomolecules with improved efficiency and decreased sample volume compared to the company's previous AQS3 pro structural analysis technology. Read More
Conferences
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
